ATE338117T1 - 5' ests für proteine, die nicht gewebespezifisch sind - Google Patents

5' ests für proteine, die nicht gewebespezifisch sind

Info

Publication number
ATE338117T1
ATE338117T1 AT98936586T AT98936586T ATE338117T1 AT E338117 T1 ATE338117 T1 AT E338117T1 AT 98936586 T AT98936586 T AT 98936586T AT 98936586 T AT98936586 T AT 98936586T AT E338117 T1 ATE338117 T1 AT E338117T1
Authority
AT
Austria
Prior art keywords
ests
proteins
tissue specific
sequences
forensic
Prior art date
Application number
AT98936586T
Other languages
English (en)
Inventor
Milne Edwards Jean-Bapti Dumas
Aymeric Duclert
Bruno Lacroix
Original Assignee
Serono Genetics Inst Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Genetics Inst Sa filed Critical Serono Genetics Inst Sa
Application granted granted Critical
Publication of ATE338117T1 publication Critical patent/ATE338117T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT98936586T 1997-08-01 1998-07-31 5' ests für proteine, die nicht gewebespezifisch sind ATE338117T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90513597A 1997-08-01 1997-08-01

Publications (1)

Publication Number Publication Date
ATE338117T1 true ATE338117T1 (de) 2006-09-15

Family

ID=25420338

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98936586T ATE338117T1 (de) 1997-08-01 1998-07-31 5' ests für proteine, die nicht gewebespezifisch sind

Country Status (11)

Country Link
EP (1) EP1000146B1 (de)
JP (1) JP2001512011A (de)
AT (1) ATE338117T1 (de)
AU (1) AU8554798A (de)
CA (1) CA2297306A1 (de)
CY (1) CY1106216T1 (de)
DE (1) DE69835751T2 (de)
DK (1) DK1000146T3 (de)
ES (1) ES2267192T3 (de)
PT (1) PT1000146E (de)
WO (1) WO1999006548A2 (de)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0929575A4 (de) * 1996-08-23 2004-09-08 Human Genome Sciences Inc Neue menschliche wachstumsfaktoren.
US6171816B1 (en) 1996-08-23 2001-01-09 Human Genome Sciences, Inc. Human XAG-1 polynucleotides and polypeptides
US6759515B1 (en) 1997-02-25 2004-07-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US20030185830A1 (en) 1997-02-25 2003-10-02 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6395278B1 (en) 1997-02-25 2002-05-28 Corixa Corporation Prostate specific fusion protein compositions
PL196260B1 (pl) 1997-02-25 2007-12-31 Corixa Corp Polipeptyd, cząsteczka DNA, komórka gospodarza, białko fuzyjne, kompozycje farmaceutyczne i szczepionki do leczenia raka prostaty
US6894146B1 (en) 1997-02-25 2005-05-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6800746B2 (en) 1997-02-25 2004-10-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6329505B1 (en) 1997-02-25 2001-12-11 Corixa Corporation Compositions and methods for therapy and diagnosis of prostate cancer
US7202342B1 (en) 1999-11-12 2007-04-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6261562B1 (en) 1997-02-25 2001-07-17 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6818751B1 (en) 1997-08-01 2004-11-16 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6620922B1 (en) 1997-02-25 2003-09-16 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7033827B2 (en) 1997-02-25 2006-04-25 Corixa Corporation Prostate-specific polynucleotide compositions
US6630305B1 (en) 1999-11-12 2003-10-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6465611B1 (en) 1997-02-25 2002-10-15 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6613872B1 (en) 1997-02-25 2003-09-02 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6943236B2 (en) 1997-02-25 2005-09-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7517952B1 (en) 1997-02-25 2009-04-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7196164B2 (en) 1997-07-08 2007-03-27 Human Genome Sciences, Inc. Secreted protein HHTLF25
WO2001066740A2 (en) * 2000-03-03 2001-09-13 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
ES2331622T3 (es) * 1997-05-07 2010-01-11 Schering Corporation Proteinas receptoras humanas similares a toll, reactivos y metodos relacionados.
US20030032090A1 (en) 1997-05-07 2003-02-13 Schering Corporation, A New Jersey Corporation Human receptor proteins; related reagents and methods
US6372473B1 (en) 1997-05-28 2002-04-16 Human Genome Sciences, Inc. Tissue plasminogen activator-like protease
US20020061576A1 (en) * 1997-05-28 2002-05-23 Paul A. Moore Tissue plasminogen activator-like protease
EP1557425A3 (de) * 1997-07-08 2005-08-17 Human Genome Sciences, Inc. Humanes sekeretiertes Protein
EP1000084A4 (de) 1997-07-08 2003-03-26 Human Genome Sciences Inc 123 vom menschen abgesonderte proteine
AU753099B2 (en) * 1997-08-01 2002-10-10 Genset S.A. Extended cDNAs for secreted proteins
US6416973B1 (en) 1997-08-01 2002-07-09 Schering Corporation Nucleic acids encoding mammalian cell membrane protein MDL-1
EP1003861B1 (de) * 1997-08-01 2006-10-04 Schering Corporation Membranproteine aus säugetierzellen; verwandte reagentien
CA2239255A1 (en) * 1997-10-23 1999-04-23 Smithkline Beecham Corporation Cdna clone hneaa81 that encodes a human 7-transmembrane receptor
EP1464653A1 (de) * 1997-11-07 2004-10-06 Human Genome Sciences, Inc. Humanes sekretiertes Protein
US6573068B1 (en) 1997-11-13 2003-06-03 Genset, S. A. Claudin-50 protein
US6548633B1 (en) 1998-12-22 2003-04-15 Genset, S.A. Complementary DNA's encoding proteins with signal peptides
JP2001523453A (ja) * 1997-11-13 2001-11-27 ジェンセット 分泌タンパク質の伸長ｃＤＮＡ
AU2002499A (en) * 1997-12-18 1999-07-05 Zymogenetics Inc. Mammalian calcitonin-like polypeptide-1
AU764441B2 (en) 1998-02-09 2003-08-21 Genset S.A. cDNAs encoding secreted proteins
WO1999041373A2 (en) * 1998-02-11 1999-08-19 Incyte Pharmaceuticals, Inc. Human transport-associated molecules
DE19811194A1 (de) * 1998-03-10 1999-09-16 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Prostatagewebe
US6365369B1 (en) 1998-04-01 2002-04-02 Human Genome Sciences, Inc. Prostate specific secreted protein
EP1086223B1 (de) 1998-06-01 2009-07-29 Agensys, Inc. Serpentintransmembranantigene exprimiert in menschlichem krebs und deren verwendungen
US6833438B1 (en) 1999-06-01 2004-12-21 Agensys, Inc. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US20040141975A1 (en) 1998-06-01 2004-07-22 Raitano Arthur B. Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
US20030149531A1 (en) 2000-12-06 2003-08-07 Hubert Rene S. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US20060052321A1 (en) 2002-04-05 2006-03-09 Raitano Arthur B Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
JP2002522016A (ja) * 1998-07-22 2002-07-23 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 神経内分泌特異的タンパク質に類似したタンパク質、およびそれをコードするｃＤＮＡ
US6902892B1 (en) 1998-10-19 2005-06-07 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
MXPA01009688A (es) * 1999-03-26 2002-03-27 Smithkline Beecham Biolog Compuestos novedosos.
JP2003521239A (ja) * 1999-04-09 2003-07-15 キュラジェン コーポレイション 新規ヒトタンパク質およびそれらをコードするポリヌクレオチド
EP1792989A1 (de) * 1999-04-12 2007-06-06 Agensys, Inc. 13-Transmembrane Protein welches in Prostatakrebs exprimiert wird
US6943235B1 (en) 1999-04-12 2005-09-13 Agensys, Inc. Transmembrane protein expressed in prostate cancer
WO2000061746A1 (en) * 1999-04-12 2000-10-19 Agensys, Inc. 13 transmembrane protein expressed in prostate cancer
US7244827B2 (en) 2000-04-12 2007-07-17 Agensys, Inc. Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
US6222027B1 (en) * 1999-05-17 2001-04-24 Incyte Genomics, Inc. Molecules expressed in hippocampus
US6951738B2 (en) 1999-07-16 2005-10-04 Human Genome Sciences, Inc. Human tumor necrosis factor receptors TR13 and TR14
CA2381327A1 (en) * 1999-07-16 2001-01-25 Steven M. Ruben Human tumor necrosis factor receptors tr13 and tr14
FR2796652B1 (fr) * 1999-07-20 2003-03-21 Inst Nat Sante Rech Med Acides nucleiques codant pour des peptides possedant l'activite biologique de la sorbine
FR2800388A1 (fr) * 1999-10-29 2001-05-04 Pf Medicament Clonage, expression et caracterisation d'un gene exprime dans des cellules tumorales et implique dans la regulation de la reponse immune
EP1235907A4 (de) * 1999-11-12 2003-07-30 Human Genome Sciences Inc 6 menschliche, ausgeschiedene proteine
WO2001060859A1 (fr) * 2000-02-21 2001-08-23 Kureha Chemical Industry Co., Ltd. Nouvelles proteines et nouveaux genes codant ces proteines
US7125687B1 (en) * 2000-05-05 2006-10-24 Exelixis, Inc. Presenilin enhancers assays
AU2001283315A1 (en) * 2000-08-10 2002-02-25 Pharmacia Corporation A hematopoietic growth factor-like protein obtained from a cdnalibrary from hs-5 stromal cell line
MXPA03001348A (es) * 2000-08-18 2004-04-05 Bristol Myers Squibb Co Homologos receptores novedosos de imidazolina.
EP1335975A2 (de) * 2000-09-01 2003-08-20 Millennium Pharmaceuticals, Inc. "47324", ein humanes g-protein und verwendungen davon
WO2002024750A2 (en) * 2000-09-21 2002-03-28 Aeomica, Inc. Human kidney tumor overexpressed membrane protein 1
US7048931B1 (en) 2000-11-09 2006-05-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7927597B2 (en) 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
WO2002083921A2 (en) 2001-04-10 2002-10-24 Agensys, Inc. Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
EP2287186B1 (de) 2001-09-06 2014-12-31 Agensys, Inc. Nucleinsäure und entsprechendes Protein, STEAP-1, bei der Behandlung und zum Nachweis von Krebs
US7494646B2 (en) 2001-09-06 2009-02-24 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
US7449548B2 (en) 2001-12-07 2008-11-11 Agensys, Inc. Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
AU2004319915B9 (en) 2004-04-22 2011-12-22 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
JP2006345831A (ja) * 2005-06-20 2006-12-28 P-Lap:Kk Ｄｎａ、ベクター、形質転換体、及びａｐａタンパク質の製造方法
BRPI0717638A2 (pt) 2006-10-27 2013-11-12 Genentech Inc Anticorpors e imunoconjugados e usos para os mesmos
MX2019011769A (es) 2017-04-03 2019-11-07 Hoffmann La Roche Anticuerpos que se unen a steap-1.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3337748B2 (ja) * 1992-09-25 2002-10-21 財団法人神奈川科学技術アカデミー 完全長ｃＤＮＡの合成方法、その中間体の製造方法及び完全長ｃＤＮＡを含む組換えベクターの製造方法
FR2733762B1 (fr) * 1995-05-02 1997-08-01 Genset Sa Methode de couplage specifique de la coiffe de l'extremite 5' d'un fragment d'arnm et preparation d'arnm et d'adnc complet
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby
EP0973899A2 (de) * 1997-04-10 2000-01-26 Genetics Institute, Inc. SEKRETIERTE EXPRIMIERTE SEQUENZMARKER (sESTs)

Also Published As

Publication number Publication date
EP1000146B1 (de) 2006-08-30
AU8554798A (en) 1999-02-22
DK1000146T3 (da) 2007-01-08
CY1106216T1 (el) 2011-06-08
WO1999006548B1 (en) 1999-06-03
PT1000146E (pt) 2006-10-31
DE69835751T2 (de) 2007-10-04
WO1999006548A2 (en) 1999-02-11
CA2297306A1 (en) 1999-02-11
ES2267192T3 (es) 2007-03-01
DE69835751D1 (de) 2006-10-12
WO1999006548A3 (en) 1999-04-08
JP2001512011A (ja) 2001-08-21
EP1000146A2 (de) 2000-05-17

Similar Documents

Publication Publication Date Title
ATE338117T1 (de) 5' ests für proteine, die nicht gewebespezifisch sind
ATE323161T1 (de) 5' ests für sekretierte proteine die im gehirn expremiert werden
ATE361933T1 (de) 5' ests für sekretierte proteine aus gehirngeweben
ATE495257T1 (de) 5' ests für sekretierte proteine, die in verschiedenen geweben exprimiert werden
WO1999006550A3 (en) 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN PROSTATE
WO1999053051A3 (en) 5' ests and encoded human proteins
WO1999006554A3 (en) 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN MUSCLE AND OTHER MESODERMAL TISSUES
ATE338064T1 (de) 5' est's für sekretierte proteine, die in verschiedenen geweben exprimiert werden
WO1999006439A3 (en) 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN ENDODERM
WO1999031236A3 (en) EXTENDED cDNAs FOR SECRETED PROTEINS
WO1999025825A3 (en) EXTENDED cDNAs FOR SECRETED PROTEINS
ATE269402T1 (de) Ikk-beta proteine, nukleinsäuren und verfahren
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
DE69633664D1 (de) Genetische marker für brust und eierstockkrebs
DE69534618D1 (de) Verfahren zur herstellung rekombinanter adeno-associated viren (aav) und deren verwendung
WO2000037491A3 (en) Dnas encoding proteins with signal sequences
EP0947583A3 (de) Expressionsaktivierende Nukleinsäurefragmente des Melanom-inhibierenden Proteins (MIA)
EP1260228A3 (de) Menschliches Wachstumsgen und minderwuchse Gen Bereich. Therapeutische Verwendungen
PT990000E (pt) Factor 3 de crescimento do tecido conjuntivo
EP1903111A3 (de) Erweiterte cDNA für sekretierte Proteine
WO1999054446A3 (de) Menschliche nukleinsäuresequenzen, die in pankreasnormalgewebe überexprimiert sind

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1000146

Country of ref document: EP

REN Ceased due to non-payment of the annual fee